The hypoxemia induced by COVID-19 is responsible for the increase in Gal-1, a lectin proven to be a major factor in pulmonary fibrosis, also considered a “hypoxia-responsive protein” [40]. The gene discussed is LGALS1; the disease is COVID-19.